| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $15.20 ▼ -0.71% | Yesterday | $15.36 ▲ +0.30% | Tomorrow's Intellia Therapeutics Inc. Common Stock (NTLA) setup is anchored to $15.31 and targets $15.20 (-0.71%). The near-term read is downside; watch $15.77 / $14.85 because daily realized volatility is about 3.65%. |
Tomorrow's Intellia Therapeutics Inc. Common Stock (NTLA) setup is anchored to $15.31 and targets $15.20 (-0.71%). The near-term read is downside; watch $15.77 / $14.85 because daily realized volatility is about 3.65%. | ||||
| Week | $14.97 ▼ -2.20% | Last Week | $15.45 ▲ +0.92% | The 7-day Intellia Therapeutics Inc. Common Stock model moves from $15.45 to $14.97 (-2.20%). It gives downside momentum context for this stock, so breaks around $15.77 / $14.85 matter more than a single tick. |
The 7-day Intellia Therapeutics Inc. Common Stock model moves from $15.45 to $14.97 (-2.20%). It gives downside momentum context for this stock, so breaks around $15.77 / $14.85 matter more than a single tick. | ||||
| Month | $14.59 ▼ -4.69% | Last Month | $15.61 ▲ +1.97% | The 1-month Intellia Therapeutics Inc. Common Stock target is $14.59 (-4.69%), compared with the live reference near $15.31. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Intellia Therapeutics Inc. Common Stock target is $14.59 (-4.69%), compared with the live reference near $15.31. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $14.02 ▼ -8.41% | Last Year | $15.85 ▲ +3.53% | The 1-year Intellia Therapeutics Inc. Common Stock scenario points to $14.02 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Intellia Therapeutics Inc. Common Stock scenario points to $14.02 (-8.41%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $12.69 ▼ -17.14% | 5 Years Ago | $16.41 ▲ +7.20% | The 5-year Intellia Therapeutics Inc. Common Stock view is $12.69 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Intellia Therapeutics Inc. Common Stock view is $12.69 (-17.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $15.31 | Mid |
| Daily Change | +0.66% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 58% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $15.31 | Daily Change | +0.66% |
| Market Cap | $1.81B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.